Literature DB >> 1658373

Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.

S F Tsang1, F Wang, K M Izumi, E Kieff.   

Abstract

To delineate the cis-acting element through which EBNA-2 transactivates latent membrane protein 1 (LMP1), we assayed the effect of EBNA-2 on the activity of LMP1 promoter upstream deletion mutants in the context of the LMP1 or heterologous promoters controlling chloramphenicol acetyltransferase (CAT) reporter gene expression in Epstein-Barr virus-negative Burkitt lymphoma cells. Assays of progressive 5' deletions of the LMP1 promoter revealed low constitutive and at least eightfold EBNA-2-stimulated activity from -512 to +40 (-512/+40), -334/+40, and -234/+40 LMP1CAT plasmids. More extensive 5'-deleted -205/+40, -155/+40, and -147/+40 LMP1CAT plasmids also had low constitutive activity but were not EBNA-2 responsive. The most 5'-deleted -55/+40 LMP1CAT plasmid had moderate constitutive activity and was not EBNA-2 inducible. Either orientation of the -334/+40 LMP1 sequence conferred EBNA-2 responsiveness when positioned upstream of an enhancerless simian virus 40 or herpes simplex virus thymidine kinase (TK) promoter. EBNA-2 and the cis-acting LMP1 DNA were both required to increase TK promoter-initiated mRNA, indicating that the EBNA-2 effect is at the transcriptional level. Further deletion analysis of the EBNA-2-responsive cis-acting element defined a -234/-92 LMP1 DNA fragment which conveyed EBNA-2 responsiveness to the herpes simplex virus TK promoter. The 5' 30 bp between -234 and -205 were essential for EBNA-2 responsiveness. Thus, these experiments define a 142-bp cis-acting element which is sufficient for conveying EBNA-2 responsiveness and an essential 30-bp component of that element. The role of this element in LMP1 and LMP2B expression and its possible role in LMP2A expression are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658373      PMCID: PMC250762     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

3.  Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.

Authors:  T Dambaugh; F Wang; K Hennessy; E Woodland; A Rickinson; E Kieff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.

Authors:  M J Allday; D H Crawford; B E Griffin
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

5.  Induction of Epstein-Barr virus nuclear antigens.

Authors:  D J Moss; T B Sculley; J H Pope
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

6.  The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  Identification of regulatory elements of cloned genes with functional assays.

Authors:  N Rosenthal
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.

Authors:  C Rooney; J G Howe; S H Speck; G Miller
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

View more
  63 in total

1.  Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.

Authors:  S H Lee; X Wang; J DeJong
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

Review 2.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; S D Hayward
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

Authors:  Nathalie Alazard; Henri Gruffat; Edwige Hiriart; Alain Sergeant; Evelyne Manet
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.

Authors:  X W Jin; S H Speck
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

Authors:  Michelle J West; Helen M Webb; Alison J Sinclair; Derek N Woolfson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Authors:  R Peng; A V Gordadze; E M Fuentes Pananá; F Wang; J Zong; G S Hayward; J Tan; P D Ling
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Authors:  Kyla Driscoll Carroll; Wei Bu; Diana Palmeri; Sophia Spadavecchia; Stephen J Lynch; Salvatore A E Marras; Sanjay Tyagi; David M Lukac
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.